Proposed Collection; 60-day Comment Request: National Institutes of Health Loan Repayment Programs, 5440-5441 [2014-02018]
Download as PDF
<![CDATA[
tkelley on DSK3SPTVN1PROD with NOTICES
5440
Federal Register / Vol. 79, No. 21 / Friday, January 31, 2014 / Notices
FDA intends to make background
material available to the public no later
than 2 business days before the meeting.
If FDA is unable to post the background
material on its Web site prior to the
meeting, the background material will
be made publicly available at the
location of the advisory committee
meeting, and the background material
will be posted on FDA’s Web site after
the meeting. Background material is
available at https://www.fda.gov/
AdvisoryCommittees/Calendar/
default.htm. Scroll down to the
appropriate advisory committee meeting
link.
Procedure: On February 28, 2014,
between approximately 8 a.m. and 9:30
a.m. and between approximately 10 a.m.
and 4:20 p.m., the meeting is open to
the public. Interested persons may
present data, information, or views,
orally or in writing, on issues pending
before the committee. Written
submissions may be made to the contact
person on or before February 21, 2014.
Oral presentations from the public will
be scheduled between approximately
2:20 p.m. and 3:20 p.m. on February 28,
2014. Those individuals interested in
making formal oral presentations should
notify the contact person and submit a
brief statement of the general nature of
the evidence or arguments they wish to
present, the names and addresses of
proposed participants, and an
indication of the approximate time
requested to make their presentation on
or before February 13, 2014. Time
allotted for each presentation may be
limited. If the number of registrants
requesting to speak is greater than can
be reasonably accommodated during the
scheduled open public hearing session,
FDA may conduct a lottery to determine
the speakers for the scheduled open
public hearing session. The contact
person will notify interested persons
regarding their request to speak by
February 14, 2014.
Closed Committee Deliberations: On
February 28, 2014, between
approximately 9:30 a.m. and 10 a.m.,
the meeting will be closed to permit
discussion where disclosure would
constitute a clearly unwarranted
invasion of personal privacy (5 U.S.C.
552b(c)(6)). The committee will discuss
the report of the intramural research
programs and make recommendations
regarding personnel staffing decisions.
Persons attending FDA’s advisory
committee meetings are advised that the
Agency is not responsible for providing
access to electrical outlets.
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with physical
VerDate Mar<15>2010
22:14 Jan 30, 2014
Jkt 232001
disabilities or special needs. If you
require special accommodations due to
a disability, please contact Prabhakara
Atreya or Denise Royster at least 7 days
in advance of the meeting.
FDA is committed to the orderly
conduct of its advisory committee
meetings. Please visit our Web site at
https://www.fda.gov/
AdvisoryCommittees/
AboutAdvisoryCommittees/
ucm111462.htm for procedures on
public conduct during advisory
committee meetings.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
Dated: January 27, 2014.
Jill Hartzler Warner,
Acting Associate Commissioner for Special
Medical Programs.
[FR Doc. 2014–01979 Filed 1–30–14; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-day Comment
Request: National Institutes of Health
Loan Repayment Programs
In compliance with the
requirement of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
for opportunity for public comment on
proposed data collection projects, the
Division of Loan Repayment, National
Institutes of Health (NIH), will publish
periodic summaries of proposed
projects to be submitted to the Office of
Management and Budget (OMB) for
review and approval.
Written comments and/or suggestions
from the public and affected agencies
should address one or more of the
following points: (1) Whether the
proposed collection of information is
necessary for the proper performance of
the function of the agency, including
whether the information will have
practical utility; (2) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) ways to minimize the
burden of the collection of information
on those who are to respond, including
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
To Submit Comments and For Further
Information: To request more
SUMMARY:
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
information on the proposed project or
to obtain a copy of the data collection
plans and instruments, contact: Steve
Boehlert, Director of Operations,
Division of Loan Repayment, National
Institutes of Health, 6011 Executive
Blvd., Room 206 (MSC 7650), Bethesda,
Maryland 20892–7650. Steve may be
contacted via email at BoehlerS@
od.nih.gov or by calling 301–451–4465.
Formal requests for additional plans and
instruments must be requested in
writing.
Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60 days of the date of
this publication.
Proposed Collection: National
Institutes of Health Loan Repayment
Programs.
Type of Information Collection
Request: Extension of a currently
approved collection (OMB No. 0925–
0361, expiration date 06/30/14).
Form Numbers: NIH 2674–1, NIH
2674–2, NIH 2674–3, NIH 2674–4, NIH
2674–5, NIH 2674–6, NIH 2674–7, NIH
2674–8, NIH 2674–9, NIH 2674–10, NIH
2674–11, NIH 2674–12, NIH 2674–13,
NIH 2674–14, NIH 2674–15, NIH 2674–
16, NIH 2674–17, NIH 2674–18, and
NIH 2674–19.
Need and Use of Information
Collection: The NIH makes available
financial assistance, in the form of
educational loan repayment, to M.D.,
Ph.D., Pharm.D., D.D.S., D.M.D., D.V.M.,
D.P.M., DC, and N.D. degree holders, or
the equivalent, who perform biomedical
or behavioral research in NIH
intramural laboratories or as extramural
grantees or scientists funded by
domestic non-profit organizations for a
minimum of 2 years (3 years for the
General Research LRP) in research areas
supporting the mission and priorities of
the NIH.
The AIDS Research Loan Repayment
Program (AIDS–LRP) is authorized by
Section 487A of the Public Health
Service Act (42 U.S.C. 288–1); the
Clinical Research Loan Repayment
Program for Individuals from
Disadvantaged Backgrounds (CR–LRP)
is authorized by Section 487E (42 U.S.C.
288–5); the General Research Loan
Repayment Program (GR–LRP) is
authorized by Section 487C of the
Public Health Service Act (42 U.S.C.
288–3); the Clinical Research Loan
Repayment Program (LRP–CR) is
authorized by Section 487F (42 U.S.C.
288–5a); the Pediatric Research Loan
Repayment Program (PR–LRP) is
authorized by Section 487F (42 U.S.C.
288–6); the Extramural Clinical
Research LRP for Individuals from
Disadvantaged Backgrounds (ECR–LRP)
E:\FR\FM\31JAN1.SGM
31JAN1
5441
Federal Register / Vol. 79, No. 21 / Friday, January 31, 2014 / Notices
is authorized by an amendment to
Section 487E (42 U.S.C. 288–5); the
Contraception and Infertility Research
LRP (CIR–LRP) is authorized by Section
487B (42 U.S.C. 288–2); and the Health
Disparities Research Loan Repayment
Program (HD–LRP) is authorized by
Section 485G (42 U.S.C. 287c–33).
The Loan Repayment Programs can
repay up to $35,000 per year toward a
participant’s extant eligible educational
loans, directly to financial institutions.
The information proposed for collection
will be used by the Division of Loan
Repayment to determine an applicant’s
eligibility for participation in the
program.
Frequency of Response: Initial
application and one or two-year renewal
application.
Affected Public: Individuals or
households; Nonprofits; and Businesses
or other for-profit.
Type of Respondents: Physicians,
other scientific or medical personnel,
and institutional representatives.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
34,925.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of respondents
Type of respondent
Estimated
number of responses per
respondent
Average burden hours per
response
Annual burden hours requested
20
20
60
1
1
1
10
1
30/60
200
20
30
Intramural LRPs
Initial Applicants ........................................................................
Advisors/Supervisors ................................................................
Recommenders ........................................................................
Subtotal .............................................................................
Extramural LRPs
Initial Applicants ........................................................................
Advisors/Supervisors ................................................................
100
........................
........................
250
1,800
1,600
1
1
11
1
19,800
1,600
Recommenders ........................................................................
5,400
1
30/60
2,700
Subtotal .............................................................................
8,800
........................
........................
24,100
Intramural LRPs
Renewal Applicants ..................................................................
Advisors/Supervisors ................................................................
40
40
1
1
7
2
280
80
Subtotal .............................................................................
Extramural LRPS
Renewal Applicants ..................................................................
Advisors/Supervisors ................................................................
Recommenders ........................................................................
80
........................
........................
360
930
690
2,790
1
1
1
8
2
30/60
7,440
1,380
1,395
Subtotal .............................................................................
4,410
........................
........................
10,215
Dated: January 27, 2014.
Adrienne Boice,
Project Clearance Liaison, Division of Loan
Repayment, NIH.
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
[FR Doc. 2014–02018 Filed 1–30–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
tkelley on DSK3SPTVN1PROD with NOTICES
National Institutes of Health
National Institute of Dental &
Craniofacial Research; Notice of
Closed Meeting Pursuant to Section
10(d) of the Federal Advisory
Committee Act, as Amended (5 U.S.C.
App.), Notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
VerDate Mar<15>2010
22:14 Jan 30, 2014
Jkt 232001
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel; RFA: DE–14–003
Date: February 28, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, #602,
6701 Rockledge Drive, Bethesda, MD 20892.
Contact Person: Jayalakshmi Raman, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institute of Dental and
Craniofacial Research, One Democracy Plaza,
Room 670, Bethesda, MD 20892–4878, 301–
594–2904, ramanj@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
Dated: January 27, 2014.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–01916 Filed 1–30–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
E:\FR\FM\31JAN1.SGM
31JAN1
]]>Agencies
[Federal Register Volume 79, Number 21 (Friday, January 31, 2014)]
[Notices]
[Pages 5440-5441]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-02018]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-day Comment Request: National Institutes
of Health Loan Repayment Programs
SUMMARY: In compliance with the requirement of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995, for opportunity for public comment
on proposed data collection projects, the Division of Loan Repayment,
National Institutes of Health (NIH), will publish periodic summaries of
proposed projects to be submitted to the Office of Management and
Budget (OMB) for review and approval.
Written comments and/or suggestions from the public and affected
agencies should address one or more of the following points: (1)
Whether the proposed collection of information is necessary for the
proper performance of the function of the agency, including whether the
information will have practical utility; (2) the accuracy of the
agency's estimate of the burden of the proposed collection of
information, including the validity of the methodology and assumptions
used; (3) ways to enhance the quality, utility, and clarity of the
information to be collected; and (4) ways to minimize the burden of the
collection of information on those who are to respond, including the
use of appropriate automated, electronic, mechanical, or other
technological collection techniques or other forms of information
technology.
To Submit Comments and For Further Information: To request more
information on the proposed project or to obtain a copy of the data
collection plans and instruments, contact: Steve Boehlert, Director of
Operations, Division of Loan Repayment, National Institutes of Health,
6011 Executive Blvd., Room 206 (MSC 7650), Bethesda, Maryland 20892-
7650. Steve may be contacted via email at BoehlerS@od.nih.gov or by
calling 301-451-4465. Formal requests for additional plans and
instruments must be requested in writing.
Comment Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 60 days
of the date of this publication.
Proposed Collection: National Institutes of Health Loan Repayment
Programs.
Type of Information Collection Request: Extension of a currently
approved collection (OMB No. 0925-0361, expiration date 06/30/14).
Form Numbers: NIH 2674-1, NIH 2674-2, NIH 2674-3, NIH 2674-4, NIH
2674-5, NIH 2674-6, NIH 2674-7, NIH 2674-8, NIH 2674-9, NIH 2674-10,
NIH 2674-11, NIH 2674-12, NIH 2674-13, NIH 2674-14, NIH 2674-15, NIH
2674-16, NIH 2674-17, NIH 2674-18, and NIH 2674-19.
Need and Use of Information Collection: The NIH makes available
financial assistance, in the form of educational loan repayment, to
M.D., Ph.D., Pharm.D., D.D.S., D.M.D., D.V.M., D.P.M., DC, and N.D.
degree holders, or the equivalent, who perform biomedical or behavioral
research in NIH intramural laboratories or as extramural grantees or
scientists funded by domestic non-profit organizations for a minimum of
2 years (3 years for the General Research LRP) in research areas
supporting the mission and priorities of the NIH.
The AIDS Research Loan Repayment Program (AIDS-LRP) is authorized
by Section 487A of the Public Health Service Act (42 U.S.C. 288-1); the
Clinical Research Loan Repayment Program for Individuals from
Disadvantaged Backgrounds (CR-LRP) is authorized by Section 487E (42
U.S.C. 288-5); the General Research Loan Repayment Program (GR-LRP) is
authorized by Section 487C of the Public Health Service Act (42 U.S.C.
288-3); the Clinical Research Loan Repayment Program (LRP-CR) is
authorized by Section 487F (42 U.S.C. 288-5a); the Pediatric Research
Loan Repayment Program (PR-LRP) is authorized by Section 487F (42
U.S.C. 288-6); the Extramural Clinical Research LRP for Individuals
from Disadvantaged Backgrounds (ECR-LRP)
[[Page 5441]]
is authorized by an amendment to Section 487E (42 U.S.C. 288-5); the
Contraception and Infertility Research LRP (CIR-LRP) is authorized by
Section 487B (42 U.S.C. 288-2); and the Health Disparities Research
Loan Repayment Program (HD-LRP) is authorized by Section 485G (42
U.S.C. 287c-33).
The Loan Repayment Programs can repay up to $35,000 per year toward
a participant's extant eligible educational loans, directly to
financial institutions. The information proposed for collection will be
used by the Division of Loan Repayment to determine an applicant's
eligibility for participation in the program.
Frequency of Response: Initial application and one or two-year
renewal application.
Affected Public: Individuals or households; Nonprofits; and
Businesses or other for-profit.
Type of Respondents: Physicians, other scientific or medical
personnel, and institutional representatives.
OMB approval is requested for 3 years. There are no costs to
respondents other than their time. The total estimated annualized
burden hours are 34,925.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Estimated
Number of number of Average burden Annual burden hours
Type of respondent respondents responses per hours per requested
respondent response
----------------------------------------------------------------------------------------------------------------
Intramural LRPs
Initial Applicants................. 20 1 10 200
Advisors/Supervisors............... 20 1 1 20
Recommenders....................... 60 1 30/60 30
------------------------------------------------------------------------
Subtotal....................... 100 .............. .............. 250
Extramural LRPs
Initial Applicants................. 1,800 1 11 19,800
Advisors/Supervisors............... 1,600 1 1 1,600
------------------------------------------------------------------------
Recommenders....................... 5,400 1 30/60 2,700
------------------------------------------------------------------------
Subtotal....................... 8,800 .............. .............. 24,100
----------------------------------------------------------------------------------------------------------------
Intramural LRPs
Renewal Applicants................. 40 1 7 280
Advisors/Supervisors............... 40 1 2 80
------------------------------------------------------------------------
Subtotal....................... 80 .............. .............. 360
Extramural LRPS
Renewal Applicants................. 930 1 8 7,440
Advisors/Supervisors............... 690 1 2 1,380
Recommenders....................... 2,790 1 30/60 1,395
------------------------------------------------------------------------
Subtotal....................... 4,410 .............. .............. 10,215
----------------------------------------------------------------------------------------------------------------
Dated: January 27, 2014.
Adrienne Boice,
Project Clearance Liaison, Division of Loan Repayment, NIH.
[FR Doc. 2014-02018 Filed 1-30-14; 8:45 am]
BILLING CODE 4140-01-P
